The upgrade of Monopar Therapeutics by a reputable financial institution like JonesTrading typically leads to increased investor confidence and a positive short-term impact on the stock's price. The direct mention of the upgrade from Hold to Buy suggests a strong bullish sentiment towards MNPR, likely leading to increased buying activity and a rise in stock price in the short term.